Skip to main content
Erschienen in: Wiener klinische Wochenschrift 1-2/2022

03.05.2021 | original article

Diabetic foot complications—lessons learned from real-world data derived from a specialized Austrian hospital

verfasst von: Sophia Rossboth, Benedikt Rossboth, Hans Schoenherr, Christian Ciardi, Monika Lechleitner, Willi Oberaigner

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 1-2/2022

Einloggen, um Zugang zu erhalten

Summary

Background

Diabetic foot complications, one of the most severe late complications of type 2 diabetes mellitus, are associated with a tremendous personal and financial burden. In order to drive the prevention of diabetic foot complications forward and facilitate early detection and personalized screening of high-risk patients, longitudinal studies are needed to identify risk factors associated with diabetic foot complications in large patient datasets.

Methods

This is a retrospective cohort study on 3002 patients with type 2 diabetes mellitus aged ≥ 18 years without prior foot complications. The data were collected between 2006 and 2017 in an Austrian hospital department specialized for diabetic patients. In addition to a univariate Cox regression analysis, multivariate Cox regression models were established to identify independent risk factors associated with diabetic foot complications and adjust for potential confounders.

Results

We observed a total of 61 diabetic foot complications in 3002 patients. In the multivariate Cox regression model, significant risk factors (hazard ratio, 95% confidence interval) for foot complications were age at diagnosis > 70 years (3.39, 1.33–8.67), male gender (2.55, 1.42–4.55), neuropathy (3.03, 1.74–5.27), peripheral arterial disease (3.04, 1.61–5.74), hypertension > 10 years after diagnosis (2.32, 1.09–4.93) and HbA1c > 9% (2.44, 1.02–5.83).

Conclusion

The identified risk factors for diabetic foot complications suggest that personalized early detection of patients at high risk might be possible by taking the patient’s clinical characteristics, medical history and comorbidities into account. Modifiable risk factors, such as hypertension and high levels of blood glucose might be tackled to reduce the risk for diabetic foot complications.
Literatur
1.
Zurück zum Zitat Federation IDIDF. Diabetes Atlas. 9th ed. 2019. Federation IDIDF. Diabetes Atlas. 9th ed. 2019.
2.
Zurück zum Zitat Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment. Diabetes Care. 2008;31(8):1679–85.PubMedPubMedCentralCrossRef Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment. Diabetes Care. 2008;31(8):1679–85.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28.PubMedCrossRef Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28.PubMedCrossRef
4.
Zurück zum Zitat Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826.PubMedCrossRef Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826.PubMedCrossRef
7.
Zurück zum Zitat Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996;13(11):967–72.PubMedCrossRef Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996;13(11):967–72.PubMedCrossRef
9.
Zurück zum Zitat de Meneses LC, Blanes L, Francescato Veiga D, Carvalho Gomes H, Ferreira ML. Health-related quality of life and self-esteem in patients with diabetic foot ulcers: results of a cross-sectional comparative study. Ostomy Wound Manag. 2011;57(3):36. de Meneses LC, Blanes L, Francescato Veiga D, Carvalho Gomes H, Ferreira ML. Health-related quality of life and self-esteem in patients with diabetic foot ulcers: results of a cross-sectional comparative study. Ostomy Wound Manag. 2011;57(3):36.
10.
Zurück zum Zitat Salomé GM, de Souza Pellegrino DM, Blanes L, Ferreira LM. Self-esteem in patients with diabetes mellitus and foot ulcers. J Tissue Viability. 2011;20(3):100–6.PubMedCrossRef Salomé GM, de Souza Pellegrino DM, Blanes L, Ferreira LM. Self-esteem in patients with diabetes mellitus and foot ulcers. J Tissue Viability. 2011;20(3):100–6.PubMedCrossRef
11.
Zurück zum Zitat Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88.PubMedCrossRef Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88.PubMedCrossRef
12.
Zurück zum Zitat Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855–62.PubMedCrossRef Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29(7):855–62.PubMedCrossRef
13.
14.
Zurück zum Zitat Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52(3):17S–22S.PubMedCrossRef Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52(3):17S–22S.PubMedCrossRef
15.
Zurück zum Zitat Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75 % of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32:195–200.PubMedCrossRef Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75 % of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32:195–200.PubMedCrossRef
16.
Zurück zum Zitat Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1993;119(1):36–41.PubMedCrossRef Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1993;119(1):36–41.PubMedCrossRef
17.
Zurück zum Zitat Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29(6):1202–7.PubMedCrossRef Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29(6):1202–7.PubMedCrossRef
18.
Zurück zum Zitat Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28(7):574–600.PubMedCrossRef Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28(7):574–600.PubMedCrossRef
20.
Zurück zum Zitat Sauseng S, Kästenbauer T, Sokol G, Irsigler K. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy. Diabetes Nutr Metab. 1999;12(3):189–93.PubMed Sauseng S, Kästenbauer T, Sokol G, Irsigler K. Estimation of risk for plantar foot ulceration in diabetic patients with neuropathy. Diabetes Nutr Metab. 1999;12(3):189–93.PubMed
21.
Zurück zum Zitat Kästenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc. 2001;91(7):343–50.PubMedCrossRef Kästenbauer T, Sauseng S, Sokol G, Auinger M, Irsigler K. A prospective study of predictors for foot ulceration in type 2 diabetes. J Am Podiatr Med Assoc. 2001;91(7):343–50.PubMedCrossRef
22.
Zurück zum Zitat Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Value Health. 2017;20(8):1003–8.PubMedCrossRef Berger ML, Sox H, Willke RJ, Brixner DL, Eichler HG, Goettsch W, et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Value Health. 2017;20(8):1003–8.PubMedCrossRef
23.
Zurück zum Zitat Oberaigner W, Oberaigner K. Diabetesregister Tirol Gesamtbericht 2006–2010. Innsbruck: IET – Insitut für klinische Epidemiologie; 2011. Oberaigner W, Oberaigner K. Diabetesregister Tirol Gesamtbericht 2006–2010. Innsbruck: IET – Insitut für klinische Epidemiologie; 2011.
24.
Zurück zum Zitat Harreiter J, Roden M. Diabetes mellitus–definition, klassifikation, diagnose, screening und prävention (update 2019). Wien Klin Wochenschr. 2019;131(1):6–15.PubMedCrossRef Harreiter J, Roden M. Diabetes mellitus–definition, klassifikation, diagnose, screening und prävention (update 2019). Wien Klin Wochenschr. 2019;131(1):6–15.PubMedCrossRef
25.
Zurück zum Zitat Radda S, Bolz M, Egger S, Gasser-Steiner V, Kralinger M, Mennel S, et al. Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung (Update 2019). Wien Klin Wochenschr. 2019;131(1):164–8.PubMedCrossRef Radda S, Bolz M, Egger S, Gasser-Steiner V, Kralinger M, Mennel S, et al. Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung (Update 2019). Wien Klin Wochenschr. 2019;131(1):164–8.PubMedCrossRef
27.
Zurück zum Zitat Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, et al. Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):27–38.PubMedCrossRef Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, et al. Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):27–38.PubMedCrossRef
28.
Zurück zum Zitat Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Berlin Heidelberg: Springer; 2010. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. Berlin Heidelberg: Springer; 2010.
29.
Zurück zum Zitat Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24.PubMedCrossRef Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24.PubMedCrossRef
30.
Zurück zum Zitat Largay J. Case study: new-onset diabetes: how to tell the difference between type 1 and type 2 diabetes. Clin Diabetes. 2012;30(1):25–6.CrossRef Largay J. Case study: new-onset diabetes: how to tell the difference between type 1 and type 2 diabetes. Clin Diabetes. 2012;30(1):25–6.CrossRef
31.
Zurück zum Zitat Younis BB, Shahid A, Arshad R, Khurshid S, Ahmad M, Yousaf H. Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan. BMC Endocr Disord. 2018;18(1):53.PubMedPubMedCentralCrossRef Younis BB, Shahid A, Arshad R, Khurshid S, Ahmad M, Yousaf H. Frequency of foot ulcers in people with type 2 diabetes, presenting to specialist diabetes clinic at a Tertiary Care Hospital, Lahore, Pakistan. BMC Endocr Disord. 2018;18(1):53.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Lai YJ, Hu HY, Lin CH, Lee ST, Kuo SC, Chou P. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001–2010. J Diabetes. 2015;7(2):260–7.PubMedCrossRef Lai YJ, Hu HY, Lin CH, Lee ST, Kuo SC, Chou P. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001–2010. J Diabetes. 2015;7(2):260–7.PubMedCrossRef
33.
Zurück zum Zitat Sarfo-Kantanka O, Sarfo FS, Kyei I, Agyemang C, Mbanya JC. Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015—a retrospective cohort study. Bmc Endocr Disord. 2019;19(1):27.PubMedPubMedCentralCrossRef Sarfo-Kantanka O, Sarfo FS, Kyei I, Agyemang C, Mbanya JC. Incidence and determinants of diabetes-related lower limb amputations in Ghana, 2010–2015—a retrospective cohort study. Bmc Endocr Disord. 2019;19(1):27.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Sheen Y‑J, Kung P‑T, Kuo W‑Y, Chiu L‑T, Tsai W‑C. Impact of the pay-for-performance program on lower extremity amputations in patients with diabetes in Taiwan. Medicine. 2018;97(41):e12759.PubMedPubMedCentralCrossRef Sheen Y‑J, Kung P‑T, Kuo W‑Y, Chiu L‑T, Tsai W‑C. Impact of the pay-for-performance program on lower extremity amputations in patients with diabetes in Taiwan. Medicine. 2018;97(41):e12759.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Tseng C‑H. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ. 2006;174(3):319–23.PubMedPubMedCentralCrossRef Tseng C‑H. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor? CMAJ. 2006;174(3):319–23.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Baba M, Davis WA, Davis TME. A longitudinal study of foot ulceration and its risk factors in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2014;106(1):42–9.PubMedCrossRef Baba M, Davis WA, Davis TME. A longitudinal study of foot ulceration and its risk factors in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2014;106(1):42–9.PubMedCrossRef
38.
Zurück zum Zitat Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30(8):964–72.PubMedCrossRef Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30(8):964–72.PubMedCrossRef
39.
Zurück zum Zitat Hu H, Han C‑M, Hu X‑I, Ye W‑I, Huang W‑J, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012;13(5):372–7.PubMedPubMedCentralCrossRef Hu H, Han C‑M, Hu X‑I, Ye W‑I, Huang W‑J, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012;13(5):372–7.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Jiang Y, Wang X, Xia L, Fu X, Xu Z, Ran X, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Rep and Reg. 2015;23(2):222–30.CrossRef Jiang Y, Wang X, Xia L, Fu X, Xu Z, Ran X, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Rep and Reg. 2015;23(2):222–30.CrossRef
41.
Zurück zum Zitat Tuttolomondo A, Casuccio A, Guercio G, Maida C, Del Cuore A, Di Raimondo D, et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol. 2017;16(1):2.PubMedPubMedCentralCrossRef Tuttolomondo A, Casuccio A, Guercio G, Maida C, Del Cuore A, Di Raimondo D, et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol. 2017;16(1):2.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Zhao J, Deng W, Zhang Y, Zheng Y, Zhou L, Boey J, et al. Association between serum Cystatin C and diabetic foot ulceration in patients with type 2 diabetes: a cross-sectional study. J Diabetes Res. 2016;2016:8029340.PubMedPubMedCentralCrossRef Zhao J, Deng W, Zhang Y, Zheng Y, Zhou L, Boey J, et al. Association between serum Cystatin C and diabetic foot ulceration in patients with type 2 diabetes: a cross-sectional study. J Diabetes Res. 2016;2016:8029340.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R, Moffet H, et al. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 2011;34(3):635–40.PubMedPubMedCentralCrossRef Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R, Moffet H, et al. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 2011;34(3):635–40.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Humphrey AR, Dowse GK, Thoma K, Zimmet PZ. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention—a 12-year follow-up study in Nauru. Diabetes Care. 1996;19(7):710–4.PubMedCrossRef Humphrey AR, Dowse GK, Thoma K, Zimmet PZ. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention—a 12-year follow-up study in Nauru. Diabetes Care. 1996;19(7):710–4.PubMedCrossRef
45.
Zurück zum Zitat Yang Y, Østbye T, Tan SB, Salam AZ‑H, Ong BC, Yang KS. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complicat. 2011;25(6):382–6.CrossRef Yang Y, Østbye T, Tan SB, Salam AZ‑H, Ong BC, Yang KS. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complicat. 2011;25(6):382–6.CrossRef
46.
Zurück zum Zitat Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21(7):1071–5.PubMedCrossRef Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21(7):1071–5.PubMedCrossRef
47.
Zurück zum Zitat Dekker RG 2nd, Qin C, Ho BS, Kadakia AR. The effect of cumulative glycemic burden on the incidence of diabetic foot disease. J Orthop Surg Res. 2016;11(1):143.PubMedPubMedCentralCrossRef Dekker RG 2nd, Qin C, Ho BS, Kadakia AR. The effect of cumulative glycemic burden on the incidence of diabetic foot disease. J Orthop Surg Res. 2016;11(1):143.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–16.PubMedCrossRef Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–16.PubMedCrossRef
49.
Zurück zum Zitat Al-Rubeaan K, Al Derwish M, Ouizi S, Youssef AM, Subhani SN, Ibrahim HM, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE. 2015;10(5):e124446.PubMedPubMedCentralCrossRef Al-Rubeaan K, Al Derwish M, Ouizi S, Youssef AM, Subhani SN, Ibrahim HM, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE. 2015;10(5):e124446.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Federation IDIDF. Diabetes Atlas. 7th ed. 2015. Federation IDIDF. Diabetes Atlas. 7th ed. 2015.
51.
Zurück zum Zitat Hu Y, Bakhotmah BA, Alzahrani OH, Wang D, Hu FB, Alzahrani HA. Predictors of diabetes foot complications among patients with diabetes in Saudi Arabia. Diabetes Res Clin Pract. 2014;106(2):286–94.PubMedCrossRef Hu Y, Bakhotmah BA, Alzahrani OH, Wang D, Hu FB, Alzahrani HA. Predictors of diabetes foot complications among patients with diabetes in Saudi Arabia. Diabetes Res Clin Pract. 2014;106(2):286–94.PubMedCrossRef
52.
Zurück zum Zitat Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care. 1995;18(4):509–16.PubMedCrossRef Selby JV, Zhang D. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care. 1995;18(4):509–16.PubMedCrossRef
53.
Zurück zum Zitat Robinson TE, Kenealy T, Garrett M, Bramley D, Drury PL, Elley CR. Ethnicity and risk of lower limb amputation in people with Type 2 diabetes: a prospective cohort study. Diabet Med. 2016;33(1):55–61.PubMedCrossRef Robinson TE, Kenealy T, Garrett M, Bramley D, Drury PL, Elley CR. Ethnicity and risk of lower limb amputation in people with Type 2 diabetes: a prospective cohort study. Diabet Med. 2016;33(1):55–61.PubMedCrossRef
54.
Zurück zum Zitat Young BA, Maynard C, Reiber G, Boyko EJ. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care. 2003;26(2):495–501.PubMedCrossRef Young BA, Maynard C, Reiber G, Boyko EJ. Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans. Diabetes Care. 2003;26(2):495–501.PubMedCrossRef
Metadaten
Titel
Diabetic foot complications—lessons learned from real-world data derived from a specialized Austrian hospital
verfasst von
Sophia Rossboth
Benedikt Rossboth
Hans Schoenherr
Christian Ciardi
Monika Lechleitner
Willi Oberaigner
Publikationsdatum
03.05.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 1-2/2022
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01864-5

Weitere Artikel der Ausgabe 1-2/2022

Wiener klinische Wochenschrift 1-2/2022 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungstipps

mitteilungen der gesellschaft

mitteilungen der gesellschaft